Accepted at 9:19 p.m. Oct, 31, 2023 by dollajas
Author: trablis
Related Note: 1503256074215
Rationale for change

Since the 2 drugs are included in the card, it's nice to ask which 2.

Text Text
Extra
- Intensive phase: 4 drugs rifampin, isoniazid, pyrazinamide, and ethambutol for 2 months (8 weeks); this phase optimizes the killing TB and decreases risk of antibiotic resistance

- Continuation phase: 2 drugs rifampin and isoniazid for 4 months (18 weeks); this phase reduces risk of relapse

- Isoniazid is administered with pyridoxine (vitamin B6) in patients at risk for peripheral neuropathy
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy



Watch Tuberculosis Drugs
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo




Bootcamp
Watch associated Bootcamp video - Mycobacteria: Pulmonary Tuberculosis Diagnostics and Management
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#B&B::18_Pulm::03_Other_Pulmonary_Topics::06_Tuberculosis #AK_Step1_v12::#AMBOSS::pNaLXO #AK_Step1_v12::^Other::^HighYield::1-HighYield #PANCE::PULM::infectious_disorders !AK_UpdateTags::Step1decks::Lolnotacop::Bugs #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::26_Antituberculous_drugs::*Rifamycins #AK_Step1_v12::#Physeo::06_Micro::02_Bacteria::41_Mycobacterium_Tuberculosis #AK_Step2_v12::#AMBOSS::gFaFhm #AK_Step1_v12::#OME::PreClinical::Microbiology::Microbiology_2::Antibacterials::Antimycobacterials #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::27_Antimycobacterial_therapy #AK_Step2_v12::#UWorld::COMLEX::28791 #AK_Original_Decks::Step_1::Lolnotacop::Bugs #PANCE::EOR::Family_med #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::03_Antimycobacterials::01_Tuberculosis_Drugs #AK_Step2_v12::#UWorld::Step::2981 #AK_Step2_v12::#AMBOSS::6j0jYT #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::26_Antituberculous_drugs::*Isoniazid #AK_Step2_v12::#B&B::08_Infectious_Disease::04_Other::04_Tuberculosis::Extra #AK_Step1_v12::#Bootcamp::Microbiology::08_Mycobacteria::04_Pulmonary_Tuberculosis_Diagnostics_And_Management #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Physeo::09_Pharm::05_Antibiotics::23_Isoniazid_(RIPE)